• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚一家三级医疗中心造影检查后对比剂肾病的发生率及危险因素

Frequency and risk factors of contrast-induced nephropathy after contrast procedures in a Nigerian tertiary centre.

作者信息

Okoye O, Ojogwu L, Unuigbe E, Oviasu E

机构信息

Nephrology Unit, Department of Medicine, University of Benin Teaching Hospital.Benin City, Edo State.

出版信息

West Afr J Med. 2013 Jan-Mar;32(1):19-25.

PMID:23613290
Abstract

Contrast-induced nephropathy (CIN) is a significant yet underestimated problem in clinical practice. The increasing use of contrast media in diagnostic and interventional procedures over the last 30 years has resulted in CIN becoming the third leading cause of hospital-acquired acute renal failure (ARF) in developed countries. Despite this, there is still a paucity of data on the incidence of CIN following intravenous contrast media especially in developing countries. The goals of this study were to determine the frequency and risk factors of CIN amongst patients receiving intravenous contrast in a tertiary health institution. This is a hospital-based prospective observational study. One hundred and eighty (180) consenting patients were recruited consecutively over a 6-month period. Venous blood and urine were collected for haematocrit, serum urea, electrolytes and creatinine estimation and urinalysis, before contrast exposure and up to 72 hours post-exposure. The frequency of CIN was 35.9% and one patient required haemodialysis. Baseline renal insufficiency, anaemia and age >55 years were significant risk factors for CIN and predictive of CIN in univariate but not multivariate analysis.

摘要

对比剂肾病(CIN)是临床实践中一个严重但被低估的问题。在过去30年中,诊断和介入操作中对比剂使用的增加导致CIN成为发达国家医院获得性急性肾衰竭(ARF)的第三大主要原因。尽管如此,关于静脉注射对比剂后CIN的发病率的数据仍然匮乏,尤其是在发展中国家。本研究的目的是确定在一家三级医疗机构中接受静脉注射对比剂的患者中CIN的发生率及其危险因素。这是一项基于医院的前瞻性观察性研究。在6个月的时间里连续招募了180名同意参与研究的患者。在对比剂注射前以及注射后长达72小时,采集静脉血和尿液进行血细胞比容、血清尿素、电解质和肌酐的测定以及尿液分析。CIN的发生率为35.9%,有1名患者需要进行血液透析。基线肾功能不全、贫血以及年龄>55岁是CIN的显著危险因素,在单因素分析中可预测CIN,但在多因素分析中则不然。

相似文献

1
Frequency and risk factors of contrast-induced nephropathy after contrast procedures in a Nigerian tertiary centre.尼日利亚一家三级医疗中心造影检查后对比剂肾病的发生率及危险因素
West Afr J Med. 2013 Jan-Mar;32(1):19-25.
2
The incidence of contrast-induced nephropathy in trauma patients.创伤患者中对比剂肾病的发生率。
Eur J Emerg Med. 2008 Jun;15(3):134-9. doi: 10.1097/MEJ.0b013e328270367d.
3
Defining incidence and outcome of contrast-induced nephropathy among trauma: is it overhyped?界定创伤患者中对比剂肾病的发病率及预后:是否被过度炒作?
Am Surg. 2011 Jun;77(6):686-9.
4
Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.II型糖尿病患者心脏导管插入术后对比剂肾病的发生率及危险因素:一项针对埃及患者的研究。
Ren Fail. 2014 Mar;36(2):191-7. doi: 10.3109/0886022X.2013.843400. Epub 2013 Oct 21.
5
The clinical and renal consequences of contrast-induced nephropathy.对比剂肾病的临床及肾脏后果。
Nephrol Dial Transplant. 2006 Jun;21(6):i2-10. doi: 10.1093/ndt/gfl213.
6
Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.对比剂肾病:定义、发病率、转归、病理生理学、危险因素及预防
Minerva Med. 2008 Apr;99(2):177-96.
7
Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.以色列住院患者中对比剂所致肾病:发病率、危险因素、住院时长及死亡率
Isr Med Assoc J. 2009 Aug;11(8):460-4.
8
[Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].[高敏C反应蛋白与直接经皮冠状动脉介入治疗后对比剂肾病之间的关联]
Zhonghua Xin Xue Guan Bing Za Zhi. 2013 May;41(5):394-8.
9
Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.抗坏血酸预防慢性肾功能损害患者冠状动脉造影后对比剂肾病:一项随机对照试验
Ther Apher Dial. 2013 Aug;17(4):384-90. doi: 10.1111/1744-9987.12083.
10
Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.茶碱预防冠状动脉造影术后对比剂肾病的疗效。
J Interv Cardiol. 2012 Aug;25(4):404-10. doi: 10.1111/j.1540-8183.2012.00730.x. Epub 2012 May 22.

引用本文的文献

1
Serum Level of Complement C1q is Associated with Contrast-Associated Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention.急诊经皮冠状动脉介入治疗患者血清补体C1q水平与造影剂相关急性肾损伤有关。
J Inflamm Res. 2021 Dec 24;14:7331-7339. doi: 10.2147/JIR.S343715. eCollection 2021.
2
Magnitude and associated factors of contrast induced nephropathy among patients undergoing coronary angiography and interventions at a cardiac referral hospital in Tanzania - a cross-sectional study.坦桑尼亚一家心脏转诊医院接受冠状动脉造影和介入治疗的患者中造影剂肾病的发生率及相关因素——一项横断面研究。
Pan Afr Med J. 2021 Mar 29;38:311. doi: 10.11604/pamj.2021.38.311.24536. eCollection 2021.
3
ACE-I/ARB therapy prior to contrast exposure: what should the clinician do?
ACE-I/ARB 治疗与造影剂暴露之间的关系:临床医生应该怎么做?
Biomed Res Int. 2014;2014:423848. doi: 10.1155/2014/423848. Epub 2014 Jan 29.